Shared decision-making—balancing clinical data with the patient's personal, logistical, and risk-tolerance factors—is essential for managing a chronic condition like follicular lymphoma.
Guidelines | NCCN Guideline Update for Follicular Lymphoma: Translating NCCN Updates Into Follicular Lymphoma Practice
NCCN Guideline Update for Follicular Lymphoma: Translating NCCN Updates Into Follicular Lymphoma Practice
Videos
The shift toward dual-targeting bispecifics and the imminent arrival of highly efficacious triple combinations could shift the follicular lymphoma treatment space.
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer
3
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
4
Orexin Agonist Shows Promise for Treating Narcolepsy, Hypersomnia: Richard Bogan, MD
5